We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$124B
AUM Growth
+$12.6B
Cap. Flow
+$4.01B
Cap. Flow %
3.23%
Top 10 Hldgs %
24.28%
Holding
4,396
New
293
Increased
2,114
Reduced
1,559
Closed
268

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$212M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$147M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$119M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$98.2M
5
AMZN icon
Amazon
AMZN
+$68.5M

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$80.8M
2
AAXJ icon
iShares MSCI All Country Asia ex Japan ETF
AAXJ
+$80M
3
NVDA icon
NVIDIA
NVDA
+$51.5M
4
BABA icon
Alibaba
BABA
+$43.1M
5
VZ icon
Verizon
VZ
+$41.6M

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Financials 8.54%
3 Healthcare 8.18%
4 Consumer Discretionary 6.58%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFFP
3376
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$327K ﹤0.01%
1,474
+2
+0.1% +$387
IHTA
3377
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$326K ﹤0.01%
33,108
-1,586
-5% -$15.7K
SCHR
3378
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$325K ﹤0.01%
11,566
-72
-0.6% -$2.03K
SGOV icon
3379
iShares 0-3 Month Treasury Bond ETF
SGOV
$101B
$325K ﹤0.01%
3,251
– –
KTF
3380
DWS Municipal Income Trust
KTF
$352M
$324K ﹤0.01%
27,418
+7,574
+38% +$90K
WLKP icon
3381
Westlake Chemical Partners
WLKP
$764M
$324K ﹤0.01%
+12,046
New +$299K
APLS
3382
DELISTED
Apellis Pharmaceuticals
APLS
$323K ﹤0.01%
6,840
-416
-6% -$16.4K
FCF icon
3383
First Commonwealth Financial
FCF
$2.19B
$323K ﹤0.01%
20,069
+1,255
+7% +$19K
PPC icon
3384
Pilgrim's Pride
PPC
$6.57B
$323K ﹤0.01%
11,461
+674
+6% +$19.2K
NRO
3385
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$322K ﹤0.01%
64,020
+262
+0.4% +$1.26K
OPK icon
3386
Opko Health
OPK
$1.04B
$322K ﹤0.01%
66,982
-13,004
-16% -$52.6K
PFD
3387
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$322K ﹤0.01%
18,378
+346
+2% +$5.79K
YEXT icon
3388
Yext
YEXT
$613M
$322K ﹤0.01%
32,508
-5,522
-15% -$62K
AXNX
3389
DELISTED
Axonics, Inc. Common Stock
AXNX
$322K ﹤0.01%
5,757
+927
+19% +$56.6K
NYF icon
3390
iShares New York Muni Bond ETF
NYF
$1.41B
$321K ﹤0.01%
5,540
+18
+0.3% +$1.04K
DLX icon
3391
Deluxe
DLX
$1.11B
$320K ﹤0.01%
9,956
+577
+6% +$20.4K
FOLD
3392
DELISTED
Amicus Therapeutics
FOLD
$320K ﹤0.01%
27,687
+1,459
+6% +$16.3K
JHX icon
3393
James Hardie Industries
JHX
$17.9B
$320K ﹤0.01%
7,860
-414
-5% -$16.2K
MDYG icon
3394
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.97B
$320K ﹤0.01%
3,922
-146
-4% -$11.7K
PGC icon
3395
Peapack-Gladstone Financial
PGC
$822M
$320K ﹤0.01%
+9,044
New +$310K
VAC icon
3396
Marriott Vacations Worldwide
VAC
$4.17B
$320K ﹤0.01%
1,891
-39
-2% -$6.27K
QUS icon
3397
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.59B
$319K ﹤0.01%
2,442
– –
UVV icon
3398
Universal Corp
UVV
$1.12B
$319K ﹤0.01%
5,817
-95
-2% -$4.74K
KEN icon
3399
Kenon Holdings
KEN
$3.53B
$318K ﹤0.01%
6,260
– –
JJSF icon
3400
J&J Snack Foods
JJSF
$1.7B
$317K ﹤0.01%
2,004
-2,604
-57% -$392K
134 135
136
137 138

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Raymond James & Associates held 4,396 positions worth $124B, up 11% from $111B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.01B of net new capital in Q4 2021, opening 293 new positions and adding to 2,114 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI All Country Asia ex Japan ETF, an estimated $80M trimmed.

  • Raymond James & Associates's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $212M increase.
  • Raymond James & Associates's biggest Q4 2021 reduction was iShares MSCI All Country Asia ex Japan ETF, cutting an estimated $80M.
  • Raymond James & Associates fully exited Kansas City Southern in Q4 2021, selling an estimated $80.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $124B portfolio in Q4 2021.
  • Raymond James & Associates opened 293 new positions and closed 268 in Q4 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $124B.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.